| Financial Year |
March 31 2023 |
| Monetary Funds |
4,254,714,197.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
110,873,599.90 |
| Accounts Receivable |
1,501,788,300.73 |
| Advances to Suppliers |
62,557,645.60 |
| Other Receivables |
60,302,755.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,045,054,216.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,602,911.02 |
| Total Current Assets |
7,213,435,989.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
31,689,299.39 |
| Long-term Equity Investment |
3,090,598,614.78 |
| Investment Properties |
56,217,124.29 |
| Fixed Assetes |
960,453,026.27 |
| Under-construction Projects |
222,790,251.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
170,191,491.57 |
| R&D expenses |
1,858,130.82 |
| Goodwill |
1,748,004.46 |
| Long-Term Deferred and Prepaid Expenses |
17,063,983.02 |
| Deferred Income Tax Assets |
55,103,269.60 |
| Other Non-Current Assets |
6,632,936.52 |
| Sub-Total of Non-Current Assets |
5,249,063,186.89 |
| Total Assets |
12,462,499,176.19 |
| Short-Term Loans |
37,909,722.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
485,731,030.07 |
| Accounts Payable |
1,585,670,055.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
53,823,100.77 |
| Taxes Payable |
13,646,259.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,266,434.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,479,496.82 |
| Other Current Liabilities |
206,542,301.47 |
| Sub-Total of Current Liabilities |
3,449,003,460.23 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,481,177.93 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,077,627.25 |
| Deferred Income Tax Liabilities |
3,778,127.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,961,336.62 |
| Total Liabilities |
3,531,964,796.85 |
| Paid-In Capital(Or Share Stock) |
859,946,895.00 |
| Capital Surplus |
2,482,731,286.02 |
| Surplus Reserve |
428,578,872.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,950,798,135.97 |
| Minority Stockholder's Interest |
172,568,899.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,757,965,480.31 |
| Owner's Equity（Stockholder's Equity） |
8,930,534,379.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,462,499,176.19 |
